Advertisement

Topics

FDA clears first wire-free radar breast tumour localisation system for long term implant capabilities

06:30 EST 15 Nov 2017 | ecancermedicalscience

The U.S. FDA have granted clearance of the SAVI SCOUT reflector for long term implant. The SAVI SCOUT reflector is an integral part of the SCOUT system for wire-free breast tumour localization. This technology is the first and only non-radioactive...

Original Article: FDA clears first wire-free radar breast tumour localisation system for long term implant capabilities

NEXT ARTICLE

More From BioPortfolio on "FDA clears first wire-free radar breast tumour localisation system for long term implant capabilities"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...